RxDoctor Payments Data

Daniel Tinker, MD

Dermatology · St Louis, MONPI 1417449869

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $76,430 of the $111,211 with a category attached, or 68.7%. UCB, Inc. accounts for 72.9% of it on its own, with 29 other manufacturers making up the rest. 2025 is the largest year on record at $90,546, more than ten times the $218 reported in 2019. Among dermatology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$111,211in general payments, 2019–2025

Across 663 payments — averaging $167.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$81K
  • Sanofi$8K
  • AbbVie$5K
  • E.r. Squibb & Sons, L.L.C.$3K
  • Arcutis Biotherapeutics, Inc.$2K
  • Galderma Laboratories, L.p.$2K
  • plus $10K from 24 others

What the payments were for

  • Consulting fees$4,3534%
  • Speaking & faculty fees$76,43069%
  • Travel & lodging$6,1786%
  • Food & beverage$24,14622%
  • Education$1050%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$111,211 in reported general payments places this provider in the 90th percentile of 263 dermatology providers in Missouri.

See all dermatology providers in Missouri

Medicare billing

Part B allowed, 2024
$49,344
Medicare patients
220
Services billed
745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa19$414,597
Dupixent PenDupilumab27$102,760
Clobetasol Propionate73$3,530
Ketoconazole141$2,596
Doxycycline Hyclate35$2,301
Tacrolimus18$2,027
Triamcinolone Acetonide80$1,224
Tretinoin21$1,174
Fluorouracil17$1,155
Hydroxyzine Hcl21$985
Metronidazole13$962
Gentamicin Sulfate22$779
Pentoxifylline29$612
CiclopiroxCiclopirox Olamine18$604
ValacyclovirValacyclovir Hcl19$352

Paid to pharmacies, not to this prescriber.

Other dermatology in St Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →